AbCellera to Participate at Upcoming Investor Conferences in November and December 2025

By: AbCellera Biologics Inc. via Business Wire

October 07, 2025 at 16:05 PM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

AbCellera (Nasdaq: ABCL) today announced that the Company will participate in the following investor conferences:

Truist Securities BioPharma Symposium, November 6, 2025
Stifel Healthcare Conference, November 11-13, 2025
Jefferies Global Healthcare Conference, November 18-20, 2025
Piper Sandler 37th Annual Healthcare Conference, December 2-4, 2025

Visit AbCellera's Investor Relations website for additional information.

About AbCellera Biologics Inc.

AbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in the areas of endocrinology, women’s health, immunology, and oncology. For more information, please visit www.abcellera.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251007123988/en/

Contacts

Inquiries

Media: Tiffany Chiu; media@abcellera.com, +1(236)521-6774

Partnering: Murray McCutcheon, Ph.D.; partnering@abcellera.com, +1(604)559-9005

Investor Relations: Peter Ahn; ir@abcellera.com, +1(778)729-9116

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Symbol	Price	Change (%)
AMZN	270.64	+0.00 (0.00%)
AAPL	312.06	+0.00 (0.00%)
AMD	516.10	+0.00 (0.00%)
BAC	51.60	+0.00 (0.00%)
GOOG	376.43	+0.00 (0.00%)
META	632.51	+0.00 (0.00%)
MSFT	450.24	+0.00 (0.00%)
NVDA	211.14	+0.00 (0.00%)
ORCL	225.78	+0.00 (0.00%)
TSLA	435.79	+0.00 (0.00%)

AbCellera to Participate at Upcoming Investor Conferences in November and December 2025

Contacts

More News

Recent Quotes